Related Experiment Video
Updated: Jun 11, 2026

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Advances in Rift Valley fever research: insights for disease prevention
A Desiree LaBeaud1, James W Kazura, Charles H King
1Children's Hospital Oakland Research Institute, Oakland, California, USA. alabeaud@chori.org
Purpose Of Review:
The purpose was to review recent research on Rift Valley fever virus (RVFV) infection, encompassing four main areas: epidemiology and outbreak prediction, viral pathogenesis, human diagnostics and therapeutics, and vaccine and therapeutic candidates.
Recent Findings:
RVFV continues to extend its range in Africa and the Middle East. Better definition of RVFV-related clinical syndromes and human risk factors for severe disease, combined with early-warning systems based on remote-sensing, simplified rapid diagnostics, and tele-epidemiology, hold promise for earlier deployment of effective outbreak control measures. Advances in understanding of viral replication pathways and host cell-related pathogenesis suggest means for antiviral therapeutics and for more effective vaccination strategies based on genetically engineered virus strains or subunit vaccines.
Summary:
RVFV is a significant health and economic burden in many areas of Africa, and remains a serious threat to other parts of the world. Development of more effective methods for RVFV outbreak prevention and control remains a global health priority.
Related Concept Videos
Respiratory Syncytial Virus Disease
Yellow Fever
Investigation of Disease Outbreaks
Infectious Diseases and Their Occurrence
Steps in Outbreak Investigation
Principles of Disease Surveillance

